Mulat Erkihun | Microbiology | Best Researcher Award

Published on by Academic Awards

Mr. Mulat Erkihun | Microbiology | Best Researcher Award

Mr. Mulat Erkihun, Debre Tabor University, Ethiopia

Mr. Mulat Erkihun Agaje is a passionate lecturer and clinical microbiologist at Debre Tabor University, Ethiopia. With extensive experience in teaching, research, and diagnostics, he also serves at Debre Tabor Comprehensive Specialized Hospital. Previously, he contributed significantly as a clinical microbiologist and laboratory technologist at Felege Hiwot Comprehensive Specialized Hospital. His expertise spans infectious disease microbiology, laboratory quality assurance, and academic curriculum development. He is deeply committed to enhancing medical education, public health diagnostics, and antimicrobial resistance research. Mr. Mulat is also actively engaged in community service and has served on university committees focused on quality assurance and curriculum review. 🧫📘👨‍⚕️

Publication Profile

Google Scholar

🎓 Education

Mr. Mulat holds a Master of Science in Medical Microbiology from Bahir Dar University (2019), graduating with “Very Great Distinction.” His curriculum included advanced bacteriology, virology, immunology, molecular techniques, and clinical microbiology. His thesis focused on Helicobacter pylori and antimicrobial resistance. He earned his Bachelor of Science in Medical Laboratory Science from Haramaya University (2016), also with “Very Great Distinction.” His undergraduate program covered diagnostic microbiology, parasitology, hematology, pathology, genetics, molecular biology, and biostatistics, incorporating research and community training. Both degrees were taught in English and emphasized practical, clinical, and research-based learning. 🎓🧪📊

🧪 Experience

Mr. Mulat has been a lecturer at Debre Tabor University since March 2022, teaching medical microbiology, supervising assessments, conducting research, and offering clinical services. From 2020 to 2022, he worked as a clinical microbiologist at Felege Hiwot Hospital, managing SOPs, inter-institutional collaborations, and antimicrobial testing. Between 2016 and 2020, he served as a medical laboratory technologist at the same hospital, performing microbiological diagnostics, microscopy, chemical analyses, and sterilization procedures. His work integrates laboratory proficiency with community engagement and academic mentorship. His commitment to diagnostic excellence and quality assurance highlights his leadership in medical microbiology. 🧬🧑‍🏫🔍

🏆 Awards and Honors

Mr. Mulat was awarded “Very Great Distinction” for both his Master’s and Bachelor’s degrees, recognizing his academic excellence. He received recognition from Bahir Dar University for his outstanding research thesis on Helicobacter pylori resistance. In 2024, he successfully secured and completed a research grant from Debre Tabor University on Lean and Six Sigma methodologies in clinical laboratory services. His contributions to committee work in curriculum review, quality assurance, and problem-based learning at Debre Tabor University have earned institutional appreciation. His dedication to clinical service and academic contribution continues to distinguish his professional journey. 🏅📜🧑‍🔬

🔍 Research Focus

Mr. Mulat’s research centers on microbial pathogens causing infectious diseases and their mechanisms of pathogenesis. His focus includes antimicrobial resistance (AMR), vaccine development, microbial genetics, and molecular diagnostics. He is particularly interested in applying nanomaterials in medical microbiology, especially concerning AMR. His expertise includes clinical bacteriology, molecular techniques like PCR, and infection control strategies. His research also explores laboratory quality improvement using methodologies like Lean and Six Sigma. Through interdisciplinary approaches, he aims to enhance diagnostic accuracy, reduce healthcare-associated infections, and combat global health challenges posed by resistant microorganisms. 🦠🧬💉

Publication Top Notes

  • 📘 Medical scope of biofilm and quorum sensing during biofilm formation: Systematic review – 11 citations, 2024

  • 🧬 Recent application of DNA microarray techniques to diagnose infectious disease – 9 citations, 2023

  • 🚽 Catheter-associated urinary tract infections in Africa: systematic review and meta-analysis – 7 citations, 2024

  • 🧫 Current Updates on Variants of SARS‐CoV‐2: Systematic Review – 6 citations, 2024

  • 🧍 Tuberculosis treatment outcome and associated factors… in Ethiopia – 4 citations, 2023

  • 🧪 Antimicrobial‐Resistance Profile of Helicobacter pylori… in Bahir Dar – 3 citations, 2023

  • 💊 Antimicrobial resistance and ESBL production in uropathogenic E. coli… in Ethiopia – 2 citations, 2024

  • 🧾 Common bacterial isolates and antibiotic susceptibility… at Felege Hiwot Hospital – 2 citations, 2023

  • 🧴 The role of extracorporeal photopheresis in graft versus host disease – 1 citation, 2024

  • 🧯 Antimicrobial resistance profile from hospital wastewater in Bahir Dar – 1 citation, 2024

 

Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Published on by Academic Awards

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. 🦠🔬📚

Publication Profile

Scopus

Orcid

🎓 Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. 🧬🔬📖

🏅 Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. 🧪🔬📚

🔬 Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance 💊, and host-pathogen interactions 🏥. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. 🌍🔍

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan 🦠💊 (Heliyon, 2025) 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025) 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🤰🦠 (Pathogens, 2025) 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases 💊🦠 (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠🧪 (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan 💊🦠 (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024) 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review 🦠📖 (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients 💉🦠 (Human Vaccines and Immunotherapeutics, 2024) 
🔟 Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives 🦠💉 (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.